Sun Pharma.Inds.

{
  "main_header": {
    "sid": 948699,
    "name": "Sun Pharma.Inds.",
    "stock_name": "Sun Pharma.Inds.",
    "full_name": "Sun Pharmaceutical Industries Ltd",
    "name_url": "stocks-analysis/sun-pharmainds",
    "exchange": 1,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,795.40",
    "chg": 42.1,
    "chgp": "2.4%",
    "dir": 1,
    "prev_price": "1,753.30",
    "mcapval": "425,018.00 Cr",
    "mcap": "Large Cap",
    "scripcode": 524715,
    "symbol": "SUNPHARMA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE044A01036",
    "curr_date": "Mar 25",
    "curr_time": "",
    "bse_nse_vol": "19.63 lacs",
    "exc_status": "Active",
    "traded_date": "Mar 25, 2026",
    "traded_date_str": "2026 03 25",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/sun-pharmainds-948699-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Sun Pharmaceutical Industries Sees Significant Open Interest Surge Amid Bullish Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-sees-significant-open-interest-surge-amid-bullish-momentum-3916520",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/SunPharmaceutic_oi_spurts_by_underlying_3916520.png",
        "date": "2026-03-25 15:00:57",
        "description": "Sun Pharmaceutical Industries Ltd has witnessed a notable surge in open interest in its derivatives segment, signalling increased market participation and potential directional bets. This development comes alongside a strong price performance, with the stock nearing its 52-week high and outperforming its sector peers, reflecting renewed investor confidence in the large-cap pharmaceutical giant."
      },
      {
        "title": "Sun Pharmaceutical Industries Ltd Surges 3.08% to Day's High of Rs 1805.9 — Outperforms Sector by 0.63 Percentage Points",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-ltd-hits-intraday-high-with-strong-308-surge-3916430",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/SunPharmaceutic_priceRelatedfactors_3916430.png",
        "date": "2026-03-25 14:16:30",
        "description": "The Sensex climbed 1.98% on 25 Mar 2026, yet Sun Pharmaceutical Industries Ltd outpaced the broader market with a 3.08% gain, reaching an intraday high of Rs 1805.9. This 0.63 percentage-point outperformance over the Pharmaceuticals & Biotechnology sector’s 2.49% advance signals a stock-specific strength rather than a mere market tailwind."
      },
      {
        "title": "Sun Pharmaceutical Industries Sees Significant Open Interest Surge Amid Bullish Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-sees-significant-open-interest-surge-amid-bullish-market-signals-3916385",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/SunPharmaceutic_oi_spurts_by_underlying_3916385.png",
        "date": "2026-03-25 14:00:43",
        "description": "Sun Pharmaceutical Industries Ltd (SUNPHARMA) has witnessed a notable surge in open interest (OI) in its derivatives segment, signalling increased market participation and potential directional bets. The stock’s recent price action, combined with rising volumes and improved market positioning, suggests a bullish sentiment among traders and investors in the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "P/E at 34.7 vs Industry's 31.5: What the Data Shows for Sun Pharmaceutical Industries Ltd",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-ltd-strengthens-position-amid-nifty-50-dynamics-3915469",
        "imagepath": "",
        "date": "2026-03-25 09:21:24",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Valuation Picture: Premium Above Industry Average</strong></p>\n                <p><a href=\"https://www.marketsmojo.com/stocks-analysis/sun-pharma.inds.-948699-0\" class=\"stk\">Sun Pharmaceutical Industries Ltd</a> trades at a P/E of 34.71, which is approximately 10% higher than the Pharmaceuticals & Biotechnology industry average of 31.53. This premium suggests that investors are willing to pay more for the stock relative to its peers, potentially reflecting expectations of superior earnings growth or a perception of higher quality within the company’s fundamentals. However, such a premium also raises questions about valuation sustainability, especially in a sector where competitive pressures and regulatory risks are prevalent. The current P/E multiple places the stock in a valu..."
      },
      {
        "title": "Sun Pharmaceutical Sees Significant Open Interest Surge Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-sees-significant-open-interest-surge-amid-mixed-market-signals-3910793",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/SunPharmaceutic_oi_spurts_by_underlying_3910793.png",
        "date": "2026-03-24 15:00:42",
        "description": "Sun Pharmaceutical Industries Ltd (SUNPHARMA) has witnessed a notable 13.37% increase in open interest in its derivatives segment, signalling heightened market activity and shifting positioning among investors. Despite this surge, the stock has underperformed its sector and broader indices over the past two days, reflecting a complex interplay between bullish bets and short-term price pressures."
      },
      {
        "title": "Sun Pharmaceutical Sees Significant Open Interest Surge Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-sees-significant-open-interest-surge-amid-mixed-market-signals-3910663",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/SunPharmaceutic_oi_spurts_by_underlying_3910663.png",
        "date": "2026-03-24 14:00:36",
        "description": "Sun Pharmaceutical Industries Ltd has witnessed a notable surge in open interest (OI) in its derivatives segment, reflecting heightened market activity and evolving investor positioning. The 12.9% increase in OI, coupled with robust volume patterns, suggests a strategic shift in directional bets amid a backdrop of mixed price momentum and sector dynamics."
      },
      {
        "title": "Sun Pharmaceutical Industries Sees Significant Open Interest Surge Amid Rising Market Activity",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-sees-significant-open-interest-surge-amid-rising-market-activity-3910532",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/SunPharmaceutic_oi_spurts_by_underlying_3910532.png",
        "date": "2026-03-24 13:00:26",
        "description": "Sun Pharmaceutical Industries Ltd has witnessed a notable surge in open interest (OI) in its derivatives segment, with a 10.12% increase to 1,24,861 contracts from 1,13,387 previously. This development, coupled with rising volumes and sustained price momentum near its 52-week high, suggests a shift in market positioning and potential directional bets among investors."
      },
      {
        "title": "P/E at 34.7 vs Industry's 31.09: What the Data Shows for Sun Pharmaceutical Industries Ltd",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-ltd-strengthens-position-amid-nifty-50-benchmark-dynamics-3909529",
        "imagepath": "",
        "date": "2026-03-24 09:21:03",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Valuation Picture: Premium Reflecting Market Confidence?</strong></p>\n                <p>The current P/E of 34.7 for <a href=\"https://www.marketsmojo.com/stocks-analysis/sun-pharma.inds.-948699-0\" class=\"stk\">Sun Pharmaceutical Industries Ltd</a> stands above the sector average of 31.09, indicating that investors are willing to pay a premium of nearly 11.6% for its earnings. This valuation premium may reflect expectations of superior earnings stability or growth prospects relative to peers. However, it also raises questions about whether the premium is justified given the stock’s recent performance and broader sector dynamics. <a href=\"https://www.marketsmojo.com/stocks-analysis/sun-pharma.inds.-948699-0\" class=\"stk\">Sun Pharma</a>’s market capitalisation of ₹4,26,685.73 crore..."
      },
      {
        "title": "P/E at 35.12 vs Industry's 31.90: What the Data Shows for Sun Pharmaceutical Industries Ltd",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-ltd-nifty-50-membership-and-institutional-dynamics-shape-market-outlook-3906718",
        "imagepath": "",
        "date": "2026-03-23 09:20:59",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Valuation Picture: Premium Above Industry Average</strong></p>\n                <p>The stock’s P/E ratio of 35.12 stands approximately 10.1% higher than the sector average of 31.90, signalling that investors are willing to pay a premium for <a href=\"https://www.marketsmojo.com/stocks-analysis/sun-pharma.inds.-948699-0\" class=\"stk\">Sun Pharmaceutical Industries Ltd</a> relative to its peers. This premium may reflect expectations of superior earnings growth or a perception of stronger fundamentals compared to the broader Pharmaceuticals & Biotechnology sector. However, such a valuation gap also raises questions about sustainability, especially given the sector’s mixed result performance so far in the current reporting season.</p>\n\n                <p><strong>Performance Across Tim..."
      }
    ],
    "total": 1026,
    "sid": "948699",
    "stock_news_url": "https://www.marketsmojo.com/news/sun-pharmaceutical-industries-948699"
  },
  "announcements": [
    {
      "details": "Sun Pharmaceutical Industries Limited has informed the Exchange regarding Intimation under Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015",
      "source": "NSE",
      "caption": "Sun Pharmaceutical Industries Limited - Other General Purpose",
      "datetime": "09-Dec-2019"
    },
    {
      "details": "Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated November 06, 2019, titled \"Sun Pharma and AstraZeneca enter into License Agreement for Novel Oncology products in China\".",
      "source": "NSE",
      "caption": "Sun Pharmaceutical Industries Limited - Press Release",
      "datetime": "06-Nov-2019"
    },
    {
      "details": "Sun Pharmaceutical Industries Limited has informed the Exchange regarding 'Please find enclosed Compliance Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018'.",
      "source": "NSE",
      "caption": "Sun Pharmaceutical Industries Limited - Updates",
      "datetime": "18-Oct-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Sun Pharmaceutical Industries Ltd has declared <strong>1100%</strong> dividend, ex-date: 05 Feb 26",
          "dt": "2026-02-05",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Sun Pharmaceutical Industries Ltd has announced <strong>1:5</strong> stock split, ex-date: 25 Nov 10",
          "dt": "2010-11-25",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Sun Pharmaceutical Industries Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 29 Jul 13",
          "dt": "2013-07-29",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Sun Pharmaceutical Industries Sees Significant Open Interest Surge Amid Bullish Momentum

2026-03-25 15:00:57

Sun Pharmaceutical Industries Ltd has witnessed a notable surge in open interest in its derivatives segment, signalling increased market participation and potential directional bets. This development comes alongside a strong price performance, with the stock nearing its 52-week high and outperforming its sector peers, reflecting renewed investor confidence in the large-cap pharmaceutical giant.

Read full news article

Sun Pharmaceutical Industries Ltd Surges 3.08% to Day's High of Rs 1805.9 — Outperforms Sector by 0.63 Percentage Points

2026-03-25 14:16:30

The Sensex climbed 1.98% on 25 Mar 2026, yet Sun Pharmaceutical Industries Ltd outpaced the broader market with a 3.08% gain, reaching an intraday high of Rs 1805.9. This 0.63 percentage-point outperformance over the Pharmaceuticals & Biotechnology sector’s 2.49% advance signals a stock-specific strength rather than a mere market tailwind.

Read full news article

Sun Pharmaceutical Industries Sees Significant Open Interest Surge Amid Bullish Market Signals

2026-03-25 14:00:43

Sun Pharmaceutical Industries Ltd (SUNPHARMA) has witnessed a notable surge in open interest (OI) in its derivatives segment, signalling increased market participation and potential directional bets. The stock’s recent price action, combined with rising volumes and improved market positioning, suggests a bullish sentiment among traders and investors in the Pharmaceuticals & Biotechnology sector.

Read full news article

P/E at 34.7 vs Industry's 31.5: What the Data Shows for Sun Pharmaceutical Industries Ltd

2026-03-25 09:21:24

Valuation Picture: Premium Above Industry Average

Sun Pharmaceutical Industries Ltd trades at a P/E of 34.71, which is approximately 10% higher than the Pharmaceuticals & Biotechnology industry average of 31.53. This premium suggests that investors are willing to pay more for the stock relative to its peers, potentially reflecting expectations of superior earnings growth or a perception of higher quality within the company’s fundamentals. However, such a premium also raises questions about valuation sustainability, especially in a sector where competitive pressures and regulatory risks are prevalent. The current P/E multiple places the stock in a valu...

Read full news article

Sun Pharmaceutical Sees Significant Open Interest Surge Amid Mixed Market Signals

2026-03-24 15:00:42

Sun Pharmaceutical Industries Ltd (SUNPHARMA) has witnessed a notable 13.37% increase in open interest in its derivatives segment, signalling heightened market activity and shifting positioning among investors. Despite this surge, the stock has underperformed its sector and broader indices over the past two days, reflecting a complex interplay between bullish bets and short-term price pressures.

Read full news article

Sun Pharmaceutical Sees Significant Open Interest Surge Amid Mixed Market Signals

2026-03-24 14:00:36

Sun Pharmaceutical Industries Ltd has witnessed a notable surge in open interest (OI) in its derivatives segment, reflecting heightened market activity and evolving investor positioning. The 12.9% increase in OI, coupled with robust volume patterns, suggests a strategic shift in directional bets amid a backdrop of mixed price momentum and sector dynamics.

Read full news article

Sun Pharmaceutical Industries Sees Significant Open Interest Surge Amid Rising Market Activity

2026-03-24 13:00:26

Sun Pharmaceutical Industries Ltd has witnessed a notable surge in open interest (OI) in its derivatives segment, with a 10.12% increase to 1,24,861 contracts from 1,13,387 previously. This development, coupled with rising volumes and sustained price momentum near its 52-week high, suggests a shift in market positioning and potential directional bets among investors.

Read full news article

P/E at 34.7 vs Industry's 31.09: What the Data Shows for Sun Pharmaceutical Industries Ltd

2026-03-24 09:21:03

Valuation Picture: Premium Reflecting Market Confidence?

The current P/E of 34.7 for Sun Pharmaceutical Industries Ltd stands above the sector average of 31.09, indicating that investors are willing to pay a premium of nearly 11.6% for its earnings. This valuation premium may reflect expectations of superior earnings stability or growth prospects relative to peers. However, it also raises questions about whether the premium is justified given the stock’s recent performance and broader sector dynamics. Sun Pharma’s market capitalisation of ₹4,26,685.73 crore...

Read full news article

P/E at 35.12 vs Industry's 31.90: What the Data Shows for Sun Pharmaceutical Industries Ltd

2026-03-23 09:20:59

Valuation Picture: Premium Above Industry Average

The stock’s P/E ratio of 35.12 stands approximately 10.1% higher than the sector average of 31.90, signalling that investors are willing to pay a premium for Sun Pharmaceutical Industries Ltd relative to its peers. This premium may reflect expectations of superior earnings growth or a perception of stronger fundamentals compared to the broader Pharmaceuticals & Biotechnology sector. However, such a valuation gap also raises questions about sustainability, especially given the sector’s mixed result performance so far in the current reporting season.

Performance Across Tim...

Read full news article

View All News